Ketamine Completed Phase 3 Trials for Inflammatory Responses / Pain / Hyperalgesia Prevention

IndicationsStatusPurposePhase
CompletedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT01301079Evaluation of the Effect of Ketamine on Remifentanil-induced Hyperalgesia